The aim of the conference is to bring together physiotherapists working in oncology from around the globe, to share knowledge, exchange best practice, and update knowledge based on recent scientific developments.
As physiotherapists play a pivotal role in helping people living with cancer to manage side- and long-term effects of cancer and cancer treatment, the overall theme of the 2023 conference is:
‘Advances in providing the best care’
With this conference, we aim to bring together physiotherapists working in oncology from around the globe, to share knowledge, exchange best practice, and update knowledge based on recent scientific developments.
The format of the conference will be a mix of plenary sessions and parallel sessions, giving the participants the opportunity to choose special areas of interest. The speakers are internationally recognized researchers, clinical experts or professional leaders. In addition, poster presentations and the opportunity to submit symposium proposals will enable you to highlight your own research.
The parallel sessions will have a varied focus: some will focus on clinical practice, other parallel sessions on scientific research, and program evaluation. More detailed information about the parallel sessions will follow later.
All accepted posters are exhibited, and some of them will be presented during the parallel sessions.
This is your chance to put together a session for the conference. Each one-hour focused symposium session will aim to create insightful and engaging learning experiences that ultimately inform, inspire, involve, and empower delegates. The conference program committee is interested in any topic related to physiotherapy in the area of oncology, but is particularly keen to see proposals that address the following focused topics:
Please review the submission guidelines, criteria, terms and conditions for focused symposia (click here)
If you would like to submit a focused symposium, please complete the Focused symposium submission form before February 28th 2023 in order for your submission to be considered. All submissions will be forwarded to the program committee for review.
We welcome poster abstracts on physiotherapy in oncology, and related topics. This includes scientific topics (finished or ongoing studies) as well as development of care pathways or implementation projects. At the 3rd ICPTO we also want to acknowledge physiotherapists that put evidence into every day clinical practice and encourage them to share their knowledge and insight. Therefore, we welcome abstracts that highlight how physiotherapy in the area of oncology is performed in the clinic and describes ‘how to’ target specifics symptoms, side-effects or long-term effects, to improve clinical practice.
Abstracts can be submitted in three categories:
Please review the submission guidelines, criteria, terms and conditions for poster abstracts (click here)
If you would like to submit a poster abstract, please complete the Poster submission form before March 31, 2023 in order for your submission to be considered. All submissions will be forwarded to the program committee for review.
On September 13 and 16, 2023 pre- and post-conference courses will be scheduled and conducted by experts in the field of oncology and physiotherapy. Details about the pre- and post-conference courses will follow later.
Before May 1, 2023: € 550,00 (‘Early Bird’)
After May 1, 2023: € 595,00
Registration includes lunch, coffee and tea breaks on both conference days, access to the handouts of all presentations and to the recorded presentations until three months after the conference.
NOTE: physiotherapists from low-income countries are offered the opportunity to register for the conference for a reduced rate. Requests in this regard can be submitted to email@example.com
September 1, 2023
For the program of the 3rd ICPTO click here
Anne May, PT, PhD
Professor of Clinical Epidemiology of Cancer Survivorship, University Medical Center Utrecht, Utrecht, the Netherlands
Margaret McNeely, PT, PhD
Professor in the Department of Physical Therapy at the University of Alberta in Edmonton, Canada
Mackenzi Pergolotti, OTR/L, PhD, MS
Senior Director of Research and Clinical Development at ReVital Cancer Rehabilitation, adjunct professor at Colorado State University and at the University of North Carolina at Chapel Hill, USA
Lisa VanHoose, PT, PhD, MPH
Clinical Professor in the Department of Physical Therapy at Baylor University in Waco, USA